Comparison of Mutant Prevention Concentrations of Fluoroquinolones Against ESBL-Positive and ESBL-Negative Klebsiella pneumoniae Isolates from Orthopedic Patients
Microbial Drug Resistance · 2024
DOI: 10.1089/mdr.2024.0023 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Microbial Drug Resistance, 2024. Verfasst von Peng Zou und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Department of Orthopedics, Zhengzhou Seventh People's Hospital, Zhengzhou, China. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Fluoroquinolones, Anti-Bacterial Agents, Microbial Sensitivity Tests. Die Arbeit nennt 43 Literaturangaben.
Abstract (Originalsprache)
The majority of Klebsiella pneumonia isolates possess the extended-spectrum beta-lactamase (ESBL) enzymes. Therefore, K. pneumoniae can easily develop drug resistance. How to effectively overcome the problem of drug resistance in K. pneumoniae is still a research hotspot. This study aimed to compare the mutant prevention concentration (MPC) of ESBL-positive and ESBL-negative K. pneumoniae isolated from orthopedic patients, which may provide a basis for the effective use of drugs to control the enrichment of resistance mutants of K. pneumoniae. The MPC90 values of 55 isolates of ESBL-positive K. pneumoniae against 4 fluoroquinolones were 32 µg/mL for levofloxacin and gatifloxacin, 16 µg/mL for ciprofloxacin, and 4 µg/mL for gemifloxacin. The selection index value was 8 for levofloxacin and ciprofloxacin and 2 for gemifloxacin and gatifloxacin, respectively. For ESBL-negative K. pneumoniae isolates, the MPC90 values were 16 µg/mL for levofloxacin and ciprofloxacin, 4 µg/mL for gemifloxacin, and 32 µg/mL for gatifloxacin. The selection index value was 8 for levofloxacin and ciprofloxacin, 2 for gemifloxacin, and 4 for gatifloxacin. For the ESBL-positive K. pneumoniae, the %T>MIC90 order was gemifloxacin > levofloxacin > ciprofloxacin > gatifloxacin. For the ESBL-negative K. pneumoniae, the %T>MIC90 order was levofloxacin > gemifloxacin > ciprofloxacin > gatifloxacin. The mutant-preventing ability of gatifloxacin and gemifloxacin was the strongest among the 4 fluoroquinolones. So gemifloxacin may be the first choice of drug to treat K. pneumoniae infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Department of Orthopedics, Zhengzhou Seventh People's Hospital, Zhengzhou, China.
Zitieren
APA
Zou, P., Chen, Z., Tu, J., Chen, X., & Liu, X. (2024). Comparison of Mutant Prevention Concentrations of Fluoroquinolones Against ESBL-Positive and ESBL-Negative Klebsiella pneumoniae Isolates from Orthopedic Patients. Microbial Drug Resistance. https://doi.org/10.1089/mdr.2024.0023
Vancouver
Zou P, Chen Z, Tu J, Chen X, Liu X. Comparison of Mutant Prevention Concentrations of Fluoroquinolones Against ESBL-Positive and ESBL-Negative Klebsiella pneumoniae Isolates from Orthopedic Patients. Microbial Drug Resistance. 2024. doi:10.1089/mdr.2024.0023
BibTeX
@article{Zou2024,
author = {Zou, Peng and Chen, Zhiquan and Tu, Jijun and Chen, Xinfeng and Liu, Xuejian},
title = {Comparison of Mutant Prevention Concentrations of Fluoroquinolones Against ESBL-Positive and ESBL-Negative Klebsiella pneumoniae Isolates from Orthopedic Patients},
journal = {Microbial Drug Resistance},
year = {2024},
doi = {10.1089/mdr.2024.0023}
}
EUVIMED